# A Study to Evaluate the Safety and Immunogenicity of MEDI7510 in Older Adults

> **NCT02289820** · PHASE1 · COMPLETED · sponsor: **MedImmune LLC** · enrollment: 363 (actual)

## Conditions studied

- Respiratory Syncytial Virus (RSV)

## Interventions

- **BIOLOGICAL:** MEDI7510
- **BIOLOGICAL:** IIV

## Key facts

- **NCT ID:** NCT02289820
- **Lead sponsor:** MedImmune LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01-05
- **Primary completion:** 2016-02-24
- **Final completion:** 2016-02-24
- **Target enrollment:** 363 (ACTUAL)
- **Last updated:** 2018-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02289820

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02289820, "A Study to Evaluate the Safety and Immunogenicity of MEDI7510 in Older Adults". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02289820. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*